Esperion Therapeutics Inc... (ESPR)
1.50
-0.11 (-6.83%)
At close: Mar 28, 2025, 3:58 PM
1.50
-0.29%
After-hours: Mar 28, 2025, 07:59 PM EDT
Esperion Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY02 | FY01 | FY00 | FY99 |
| Net Income | -51.74M | -209.25M | -233.66M | -269.11M | -143.55M | -97.17M | -201.81M | -166.99M | -74.98M | -49.78M | -36.38M | -26.09M | -11.74M | -10.82M | -28.73M | -24.93M | -27.58M | -10.67M |
| Depreciation & Amortization | 63K | 164K | 500K | 612K | 547K | 319K | 265K | 258K | 252K | 236K | 160K | 70.55K | 139.43K | 178.47K | -1.29M | -2.01M | -2.05M | -683.22K |
| Stock-Based Compensation | 11.99M | 11.96M | 15.21M | 24.31M | 28.39M | 25.88M | 23.97M | 18.61M | 15.96M | 12.73M | 3.68M | 1.23M | 79.86K | 78.45K | n/a | n/a | n/a | n/a |
| Other Working Capital | n/a | 50.18M | 2.63M | 10.39M | -490K | 8.76M | 4.71M | 708K | 6.09M | -756K | 550K | 1.47M | -625.27K | 182.68K | 777K | -249K | 356K | 3.14M |
| Other Non-Cash Items | 16.04M | 47.96M | 46.49M | 35.53M | 33.8M | 8.12M | -217K | 23K | 44K | 61K | 31K | 936.58K | 1.5M | 581.47K | 3.92M | 5.24M | 8.7M | 1.64M |
| Deferred Income Tax | n/a | n/a | n/a | -2.63M | -97K | -200K | n/a | 334K | 1.01M | 694K | 233K | 2.51M | 51.97K | 108.31K | n/a | n/a | n/a | n/a |
| Change in Working Capital | n/a | 13.68M | -3.37M | -52.51M | -4.26M | -7.3M | 29.16M | 16.47M | 9.98M | -2.09M | 251K | 3.23M | -840.17K | 801.92K | -465K | -1.06M | 2.98M | 1.86M |
| Operating Cash Flow | -23.65M | -135.49M | -174.83M | -263.81M | -85.18M | -70.34M | -148.64M | -131.3M | -47.73M | -38.16M | -32.02M | -18.11M | -10.81M | -9.07M | -26.56M | -22.77M | -17.95M | -7.85M |
| Capital Expenditures | -317K | n/a | n/a | n/a | -13.37M | -953K | -151K | -19K | -94K | -325K | -873K | -31.37K | -6.78K | -33.63K | -1.16M | -2.02M | -1.34M | -1.56M |
| Acquisitions | n/a | n/a | n/a | n/a | 12.5M | -65.18M | n/a | n/a | n/a | 24K | n/a | n/a | n/a | n/a | n/a | n/a | -233K | n/a |
| Purchase of Investments | n/a | n/a | -59.9M | -50.48M | -4.42M | -34.33M | -25.48M | -219.58M | -197.23M | -280.56M | -48.09M | -24.68M | n/a | n/a | -37.22M | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | 42.5M | 68M | n/a | 39.15M | 99.51M | 166.08M | 183.74M | 207.44M | 120.79M | 12.35M | 3.5M | n/a | 500.35K | 32.86M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | 8.1M | -50.48M | -12.5M | 65.18M | 140.6M | -35.83M | 10.21M | 24K | 12K | 201.26K | 5.1K | 42.31K | 30K | -105K | -450K | n/a |
| Investing Cash Flow | -317K | 42.5M | 8.1M | -50.48M | 21.36M | 64.23M | 140.45M | -35.85M | 10.12M | -160.07M | -36.6M | -21M | -1.68K | 509.03K | -5.48M | -2.13M | -2.02M | -1.56M |
| Debt Repayment | 35.01M | n/a | n/a | n/a | 271.6M | n/a | -1.05M | -1.71M | -1.6M | -638K | 4.84M | n/a | 15.41M | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | -55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -39.72M | -6.42M | -58.24M | 49.53M | -14.87M | 136.19M | 11.74M | 1.17M | 45K | 1.18M | 92.28M | 89.02M | 10.00 | 6.72M | 1.44M | 25.02M | 84.12M | 2.78M |
| Financial Cash Flow | 86.48M | 50.46M | 32.61M | 268.22M | 201.72M | 136.19M | 10.69M | 163.46M | -1.56M | 190.52M | 97.12M | 89.14M | 15.75M | 6.72M | 1.44M | 25.02M | 84.12M | 2.78M |
| Net Cash Flow | 62.51M | -42.53M | -134.12M | -46.07M | 137.9M | 130.09M | 2.5M | -3.7M | -39.17M | -7.7M | 28.5M | 50.03M | 4.94M | -1.84M | -29.79M | 58K | 64.32M | -6.64M |
| Free Cash Flow | -23.97M | -135.49M | -174.83M | -263.81M | -98.55M | -71.29M | -148.79M | -131.32M | -47.82M | -38.48M | -32.89M | -18.14M | -10.82M | -9.1M | -27.72M | -24.79M | -19.3M | -9.42M |